PUBM, MEVT, IVIT, XMDC, AEMD, PMDP OTCPicks.com Stocks to Watch for Friday, October 23rd

Our Stocks to Watch tomorrow include Public Media Works Inc. (OTCBB: PUBM), MSE Enviro-Tech Corp. (OTC: MEVT), Invicta Group Inc. (OTC: IVIT), XTend Medical Corp. (OTC: XMDC), Aethlon Medical Inc. (OTCBB: AEMD) and Plateau Mineral Development Inc. (OTC: PMDP).

PUBLIC MEDIA WORKS INCORPORATED (OTCBB: PUBM)

"Up 120.00% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/PUBM.php

Public Media Works, Inc. and its subsidiaries engage in the development, production, marketing, and distribution of entertainment media for fan based audiences in the United States. The company develops various feature film and television projects for daily soap opera fans, game show fans, and horror movie fans. It also owns and maintains the Internet domain names: publicfilmworks.com, publicmediaworks.com, and publicmusicworks.com. The company was founded in 2000 and is headquartered in Van Nuys, California.

PUBM News:

October 16 - Public Media Works Releases Income Statement

Visit http://finance.yahoo.com/q/is?s=pubm.ob to view the most recent income statement for Public Media Works, Inc. (OTCBB: PUBM).

MSE ENVIRO-TECH CORPORATION (OTC: MEVT)

"Up 98.00% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/MEVT.php 

MEVT owns the United States marketing rights to the Hartindo line of anti-fire products that represent an extraordinary and proven technology for fighting and preventing accidental fires. The environmentally friendly Fire Extinguishing and Fire Inhibiting properties of Hartindo products address a wide range of critical needs in fire prevention, including the overall goal of lowering the enormous losses, in both life and property, caused by accidental fires across North America each year. MEVT is planning a marketing campaign and the establishment of a nationwide network of agents and distributors for the exciting Hartindo product line.

MEVT News:

October 9 - MSE Enviro-Tech Corp. Awarded Exclusive Rights to Distribute Specialty Concrete Coating Products Throughout the Caribbean

MSE Enviro-Tech Corp. (OTC: MEVT) (Frankfurt: MEH) announced that it has acquired from IMCO Technologies Inc. the exclusive rights to distribute IMCO's patented products designed to protect and enhance the performance of concrete structures, which covers the vast majority of residential and commercial buildings in the Caribbean. In keeping with the Company's goal of expanding its product offerings in light of rising demand for environmentally friendly, technology based products, this exclusive distributorship compliments MEVT's primary business and offers additional potential for growth and enhancement of corporate value.

Throughout the Caribbean, the IMCO® concrete preservation and maintenance products will be distributed by MEVT in the same manner of marketing being planned for its specialized fire inhibiting coatings to the construction industry.

"Successful acquisition of the rights to distribute the IMCO® products expands MEVT's marketing and growth potential through the addition of another important dimension to the Company's line of building protection products. We are increasingly optimistic regarding the outlook for the Company's marketing plans given this exciting new addition," said Mr. Gilles Trahan, CEO-President of MSE Enviro-Tech Corp.

ABOUT IMCO TECHNOLOGIES INC.

Since 1982, IMCO® products have solved concrete and steel maintenance problems worldwide. With a background as engineers and industrial contractors, and equipped with unique chemical technologies, the company set out to develop protective coating systems and concrete repair materials and has exceeded those goals. Each product has been developed to meet a particular challenge within the construction, plant maintenance and building restoration businesses. Over the years, IMCO® products have earned a rising profile in construction and engineering companies across North America and around the globe, owing to their ability to vastly improve the performance of concrete across a broad range of applications. Importantly, IMCO® products address the industry's critical needs more cost effectively and with lower ongoing maintenance costs than conventional products.

INVICTA GROUP INCORPORATED (OTC: IVIT)

"Up 57.14% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/IVIT.php

Invicta Group, Inc. is a full service multimedia management and marketing company. Invicta utilizes a number of websites, a large database, event productions and promotions, and its experienced team to help clients manage, maintain and improve their overall businesses. Current projects include: Water Tower Surgical Center, TravelHotLink.com and TicketHotlink.com.

IVIT News:

October 15 - The Invicta Group Acquires IMAGE Chicago Magazine and the IMAGE Brands From STL Marketing Group

The Deal Allows Invicta to Add an Established Media Brand While STL Can Focus More on Their Core Business and Reduce Some Liabilities

Invicta Group Inc. (OTC: IVIT) announced that the company has acquired specific assets related to IMAGE Chicago Magazine and the IMAGE Worldwide brands. The main purpose of this new acquisition is to help the Invicta Group expand their media, marketing, event production, and event promotion services.

IMAGE Chicago Magazine and IMAGE Worldwide have been involved with 100s of special events ranging from celebrity appearances, fashion shows, product launch events, and other types of events during the past 5 years. IMAGE has also been printing the magazine IMAGE Chicago for the past 4 years. IMAGE has built a solid brand in the entertainment, fashion, and health and beauty industry. The current staff will stay on board and work with the Invicta Group.

Invicta is going to revamp the magazine to focus a larger portion on health and beauty and tie in the medical community, especially those involved with the Water Tower Surgery Center. The magazine will still cover celebrities and fashion but will expand its coverage and distribution to include more of the health and beauty industries.

STL Marketing Group CEO Steven St. Louis said, "Our core businesses include printing, packaging, and design solutions and this sale helps us improve our balance sheet and focus more on our core businesses."

Invicta Group's CEO Paul Sorkin said, "This is another great acquisition for the Invicta Group. IMAGE is a perfect fit for the Water Tower Surgery Center. A person's health and beauty help define their IMAGE and we couldn't think of a better way to help doctors showcase and market their IMAGE in print, online, and at events. The new magazine will be released in early December and will include some expanded editorial along with some additional relevant strategic distribution."

ABOUT IMAGE CHICAGO MAGAZINE

IMAGE Chicago Magazine is an entertainment and lifestyle magazine that focuses on everything in fashion, health, beauty, and entertainment for the Windy City. IMAGE provides its readers with the latest on what's hot today and what will be tomorrow. IMAGE features the best in celebrity interviews, editorial content on fitness, fashion, beauty, music, relationships and more, along with some incredible fashion spreads and photo galleries. By using both print and online media IMAGE has created an interactive relationship with its readers and continues to inform and entertain.

ABOUT STL MARKETING GROUP

STL Marketing Group is committed to brand movement through Three distinct vehicles: creative and design services, packaging and supply solutions, printing and mailing. These core business units allow for supply chain synergy and a one-stop shop approach for clients to achieve their strategic communications objectives. Vertical integration and cross promotion between company sectors allows STL Marketing Group the ability to share key resources, maximize efficiencies, and utilize economies of scale. These components improve buying power for the corporation and increase value for clients and shareholders. STL Marketing Group will utilize a blend of products, services, and relationships to create an extraordinary customer experience and foster unbounded company growth.

XTEND MEDICAL CORPORATION (OTC: XMDC)

"Up 53.85% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/XMDC.php 

XTend Medical is a company that specializes in the manufacturing and distribution of the latest in telemedicine and telehealth solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their continued efforts in identifying global companies with true product potential in the healthcare industry puts them in an advantageous position to capitalize on a global basis.

XMDC News:

October 22 - XTend Medical Updates Shareholders on Merger and Company's Progress

Management to Travel to Korea to Finalize Merger

XTend Medical Corp. (OTC: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the company's progress on merger and company's progress:

"XTend would like to update our shareholders on our progress to date. Mr. Lee from BioHarp, Korea traveled to Los Angeles last weekend to meet with the executives of XTend. The meetings were very positive and included several aspects in the manufacturing process and the business model moving forward. I personally want to thank Mr. Lee for his dedication and efforts in moving the merger forward. The management of XTend will be traveling to Korea soon to meet with the executives of BioHarp, Korea to finalize the merger. We also intend to secure the manufacturing relationships Mr. Lee has worked on over the past months in order to fulfill our needs for the BioHarp unit. Mr. Lee has identified several major manufacturers that can handle the volume of devices we'll need to fulfill the commitments we expect over the next 6-12 months and having strategic manufacturing partners in Korea to work closely with the technical staff is imperative to the success of the company. While in Korea, XTend management will also be looking to secure a listing on the Korean Stock Exchange that will add to our shareholder base on a global basis and gain additional exposure for the company.

The combined efforts of the seasoned technical team in Korea with the management in the U.S. will insure that the BioHarp device will become the standard in medical diagnosis. Our intention is to market the product aggressively throughout Asia, the U.S. and Europe. To date, we've had over 7 inquiries from medical device companies looking to represent the BioHarp in 4 different countries globally. As we move forward, these opportunities will be explored and if they benefit the company, we will press forward on a working relationship.

As to the BioHarp unit itself, I would like to reiterate a few areas that make this device unique:

1. The BioHarp requires a pre-scan of the patient in order to get a baseline reading. This baseline reading is not based solely on a set of standards in the medical sector. These individualized baselines are established from the patient's own cellular makeup and further solidify how the BioHarp sets itself apart from any present of future competitors.

2. The BioHarp device is completely portable. Unlike CT Scanners and other large pieces of equipment that remain stationary, the BioHarp can travel to where the patients are. The unit is perfect for rural areas, battlefields, or other outlying areas that would benefit by having the BioHarp as part of their healthcare service.

3. BioHarp can be used to detect cellular inflammation in plants. Diseases in crops have risen dramatically over the years and the BioHarp can assist scientists in helping to determine the proper course of treatment in order to insure plants can sustain life. The global percussion in this area can be tremendous for the company.

4. The dedication Mr. Lee has spent on this device over the past 14 years is truly incredible. His vision for this device has proven instrumental in the development of the BioHarp. His technical staff has, and continues t, spend countless hours perfecting this product and we feel honored to become part of this exciting and truly unique product.

In closing, I would like to thank all of our shareholders for being patient as we close this merger. Mr. Lee and I have worked continuously over the past two years to insure you, as shareholders, will reap the benefits of being part of something we're very proud of. The future is very bright for this company and through hard work and dedication, the BioHarp will flourish and become the leading diagnostic device in the global medical community," stated Mr. Paul D. Lisenby, CEO of XTend Medical.

AETHLON MEDICAL INCORPORATED (OTCBB: AEMD)

"Up 46.88% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/AEMD.php

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.

AEMD News:

October 22 - Aethlon Medical Establishes Exosome Sciences, Inc.

Aethlon Medical, Inc. (OTCBB: AEMD) announced that it has established Exosome Sciences, Inc. (ESI) as a wholly owned subsidiary of the Company. ESI will seek to leverage the recent discovery that the Hemopurifier®, a medical device developed by Aethlon Medical as a broad-spectrum therapy against infectious viral pathogens, is effective in capturing exosomes that are secreted by solid tumors, lymphomas, and leukemia to suppress the immune response in cancer patients. Aethlon Medical, Inc. will contribute into ESI all exosome-related patents and patents pending.

Jim Joyce, Chairman and Chief Executive Officer of Aethlon Medical, Inc. said, "The ability to reduce circulating exosomes would likely reverse immune suppression and increase patient responsiveness to both immunotherapy and chemotherapy, thus positioning ESI to participate in the $43 billion cancer therapy market. ESI also plans to advance exosome diagnostic and research services, and explore recently discovered opportunities to address exosomes in disease conditions beyond cancer."

In the last year alone, an increasing number of research driven science publications reveal that exosomes have implications in inflammatory conditions including Sepsis, bacterial infections including Tuberculosis (TB), autoimmune conditions such as Rheumatoid Arthritis, and neurological and neurodegenerative diseases such as Alzheimer's disease The growth in the exosome industry is further evidenced by published research and citations increasing from 140 articles in 2001 to 1,160 articles and citations in 2008.

"ESI allows us to leverage the previously unrecognized value of our non-infectious disease research into a new asset that positions us to be an important participant in the emerging exosome industry. We also maintain the option of installing an independent management team at ESI and if appropriate in the future, may spin out part or all of ESI as a means to achieve fuller valuation for Aethlon Medical shareholders," concluded Joyce.

A recent publication entitled, "Exosomes as a Tumor Immune Escape Mechanism: Possible Therapeutic Implications" discusses the potential for the Hemopurifier® to become the first therapeutic strategy to inhibit the immune suppression caused by tumor secreted exosomes.

PLATEAU MINERAL DEVELOPMENT INCORPORATED (OTC: PMDP)

"Up 30.00% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/PMDP.php 

Plateau Mineral Development, Inc. specializes in the exploration and development of energy sources. Its partner, Plateau Mineral Development LLC, has been in existence for over five years with successful new wells and rework wells selling both gas and oil.

PMDP News:

July 15 - Plateau Mineral Development, Inc. Announces Solar Collector

Plateau Mineral Development, Inc. (OTC: PMDP), along with its partner, Plateau Mineral Development LLC, announced today that the firm, in conjunction with MEI, is moving to secure several features of its improved solar collector.

The unit, produced and installed in the early 1980s, is being upgraded with the inclusion of photo-voltaic capability. The unit acts as a concentrator under clear skies and as a flat plate when sunlight is diffused by dust or clouds.

A representative of Plateau Mineral Development states, "Additionally, a research and development plan and budget have been prepared to research means of enhancing the photo-voltaic output. Understandably, aspects of this research and development are being held in strictest confidence. We will update our shareholders on portions of the research that are deemed appropriate for dissemination as soon as the details are available to us."

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: OTCPicks.com have been compensated eight thousand dollars by a third Party (Geneva Bancorp) for MEVT advertising and promotional services.